LOADING
Comparing Eli Lilly and Company (LLY) and Mastercard Inc (MA) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | MA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $982.8B | $427.7B |
| P/E Ratio | 39.2 | 28.0 |
| Forward P/E | 30.3 | 24.7 |
| PEG Ratio | 1.47 | 1.49 |
| EPS | $28.10 | $17.28 |
| Revenue Growth (YoY) | 55.5% | 15.8% |
| Profit Margin | 35.0% | 45.9% |
| Return on Equity | 107.5% | 232.1% |
| Dividend Yield | 0.57% | 0.67% |
| Beta | 0.52 | 0.74 |
| 52-Week High | $1,182.73 | $599.05 |
| 52-Week Low | $619.40 | $464.52 |
| Volume | -- | -- |
Eli Lilly and Company is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Mastercard Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.